Insulinoma with hyperproinsulinemia during hypoglycemia and loss of expression of vacuolar-type H+-ATPase (V-ATPase) in the tumor tissue

International Journal of Pancreatology

Volumn 25, Issue 1, 1999, Pages 11-16

  Hiura, Akihito ^b   Kim, Eui Chul ^b   Ikahara, Teruyuki ^b   Mishima, Kouichi ^b   Shindo, Kiyo ^b   Ohta, Tetsuo ^b   Satake, Katsusuke ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Insulinoma; Proinsulin; V ATPase

Indexed keywords

PROINSULIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;

AGED; ARTICLE; CASE REPORT; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

AGED; FEMALE; HUMANS; HYPERINSULINISM; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN; INSULINOMA; PROINSULIN; PROTON-TRANSLOCATING ATPASES; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 0032958255     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. 1 Alserver RN, Robert JP, Geber JG, Mako ME, Rubenstein AH. Insulinoma with low circulating insulin levels: The diagnostic value of proinsulin measurement. Ann Intern Med 1975; 82: 347-350.
2. 2 Rubenstein AH, Kuzuya H, Horwitz DL. Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycemic disorders. Arch Intern Med 1977; 137: 625-632.
3. 3 Steiner DF, Oyer PE. The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Sci USA 1967; 57: 473-480.
4. 4 Robbins DC, Tager HS, Rubenstein AH. The biologic and clinical importance of proinsulin. N Engl J Med 1984; 310: 1165-1175.
5. 5 Gorden P, Roth J, Hendric CM, Kahn CR. Plasma proinsulin-like components. Isr J Med Sci 1974; 10: 1212-1221.
6. 6 Gorden P, Sherman B, Roth J. Proinsulin-like component of circulating insulin in the basal states in patients and hamsters with islet cell tumors. J Clin Invet 1971; 50: 2113-2122.
7. 7 Orci L, Ravazzola M, Amherdt M, Madsen O, Vassalli JD, Perrelet A. Direct identification of prohormone conversion site in insulin-secreting cells. Cell 1985; 42: 671-681.
8. 8 Orci L, Ravazzola M, Amherdt M, Madsen O, Perrelet A, Vassalli JD, et al. Conversion of proinsulin to insulin occurs coordinately with acidification of maturing secretory vesicles. J Cell Biol 1986; 10: 2273-2281.
9. 9 Orci L, Ravazzola M, Storch M, Anderson R, Vassalli JD, Perrelet A. Proteolytic maturation of insulin is a post-Golgi event which occurs in acidifying clathrin-coated secretory vesicles. Cell 1987; 49: 865-868.
10. 10 Bailyes EM, Shennan KIJ, Seal AJ, Smeekens SP, Steiner Df, Hutton JC, et al. A member of the eukarytic family (PC3) has the enzymatic properties of the type 1 protein-converting endopeptidase. Biochem J 1992; 285: 391-394.
11. 11 Bennet DL, Bailyes EM, Nielsen E, Guest PC, Rutherford NG, Arden SD, et al. Identification of type 2 proinsulin procesing endopeptidase as PC2, a member of the eukaryote subtilisin family. J Biol Chem 1992; 267: 15,229-15,236.
12. 12 Davidson HW, Rhodes CJ, Hutton JC. Intraorganelle calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidase. Nature (Lond) 1988; 333: 93-96.
13. 13 Smeekens SP, Steiner DF. Identification of a human insulinoma cDNA encoding a novel mammalian protein structually related to the yeast dibasic processing protease Kex2. J Biol Chem 1990; 265: 2997-3000.
14. 14 Smeekens SP, Avruch AS, LaMendola J, Chan SJ, Steiner DF. Identification of a cDNA encoding a second putative prohormine convertase elated to PC2 in AtT20 cells and islets of Langerhans. Proc Natl Acad Sci USA 1991; 88: 340-344.
15. 15 Smeekens SP, Montag AG, Thomas G, Albiges-Rizo C, Carroll R, Benig M, et al. Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc Natl Acad Sci USA 1992; 89: 8822-8826.
16. 16 Orci L, Halban P, Perrelet A, Amherilt M, Ravazzola M, Anderson RGW. Ph-independent and -dependendt cleavage of proinsulin in the same secretory vesicles. J Cell Biol 1994; 126: 1149-1156.
17. 17 Forgac M. Structure and function of the vacuolar class of ATP-driven protein pumps. Physiol Rev 1989; 69: 765-796.
18. 18 Forgac M. Structure, function and regulation of the coated vesicle V-ATPase. J Exp Biol 1992; 172: 155-169.
19. 19 Nelson N. Structure and pharmacology of the proton-ATPase. Trend Pharmacol Sci 1991; 12: 71-75.
20. 20 Grant JA, Pallota JA, Soelder JS. Blood sugar, serum insulin, and fatty acid interrelationships during untravenous tolubutamide testing in normal young adults and the patients with insulinoma. Diabetes 1970; 19: 122-126.
21. 21 Fajans SS, Floyd JC. Fasting hypoglycemia in adults. N Engl J Med 1976; 294: 766-772.
22. 22 Turner RC, Oakley NW, Nabarro JDN. Control of basal insulin secretion, with special reference to diagnosis ofinsulinomas. Br Med J 1971; 17: 132-135.
23. +-ATPase in human pancreatic cancer. Br J Cancer 1996; 73: 1511-1517.
24. 24 Ishii H, Ito T, Moriyama S, Horie S, Tsuchiya M. Insulinoma. A statistical review of 433 cases in Japan. Jpn Clin Med 1993; 51: 199-206.